The nation of Zimbabwe has turned down a major US health deal worth $367m (£272m) spanning five years due to Washington's demand for sensitive data.
The decision was revealed after a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "unbalanced".
A government spokesperson has since stated that the United States was demanding access to biological samples for research and commercial gain while was not willing to guarantee the resulting advantages from future treatments.
"We are forced to start the difficult and regrettable task of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for further negotiations to reach a agreement acceptable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Implications
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court suspended a similar deal with the US after concerns were raised about the security of citizens' medical information.
After returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government agreements to enhance transparency and accountability.
According to statements, 16 nations in Africa have so far signed these new agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported initiatives," the Ambassador said.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no corresponding promise of access to any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"In essence, our country would supply the basic resources for medical research without any certainty that the end products would be available to our people should a new health crisis emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting structures already established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.
"This framework is intended to ensure that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to create them."
These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to further dialogue with our US partners on how subsequent co-operation could be structured in a manner that respects the independence and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that talks need to persist considering a large portion of the country's Aids initiatives were funded by international support.
"If technical issues exist, such as those involving information security or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," the group commented.
This impasse emphasises the complex tensions between receiving crucial international aid and safeguarding national sovereignty in an ever more interconnected world.